Zomedica to Report Second Quarter 2024 Financial Results and Provide Business Update on August 14 at 4:30 p.m. ET
Zomedica Corp. (NYSE American:ZOM), a veterinary health company specializing in point-of-care diagnostic and therapeutic products for equine and companion animals, has announced its upcoming second quarter 2024 financial results conference call. The event is scheduled for Wednesday, August 14, 2024, at 4:30 p.m. ET. During the call, management will discuss the company's operational and financial highlights for the quarter ended June 30, 2024, followed by a question-and-answer session.
Interested parties can join the live call via phone or webcast. For those unable to attend, a dial-in replay will be available until August 28, 2024. This announcement demonstrates Zomedica's commitment to transparency and shareholder communication, providing investors with an opportunity to gain insights into the company's recent performance and future outlook.
Zomedica Corp. (NYSE American:ZOM), un'azienda di salute veterinaria specializzata in prodotti diagnostici e terapeutici per animali da compagnia ed equini, ha annunciato la sua prossima conferenza telefonica sui risultati finanziari del secondo trimestre del 2024. L'evento è programmato per mercoledì 14 agosto 2024, alle 16:30 ET. Durante la chiamata, la direzione discuterà i risultati operativi e finanziari per il trimestre conclusosi il 30 giugno 2024, seguita da una sessione di domande e risposte.
Le parti interessate possono partecipare alla chiamata in diretta tramite telefono o webcast. Per coloro che non possono partecipare, sarà disponibile una registrazione della chiamata fino al 28 agosto 2024. Questo annuncio dimostra l'impegno di Zomedica per la trasparenza e la comunicazione con gli azionisti, offrendo agli investitori l'opportunità di acquisire informazioni sulle recenti performance dell'azienda e sulle prospettive future.
Zomedica Corp. (NYSE American:ZOM), una empresa de salud veterinaria especializada en productos diagnósticos y terapéuticos de atención al paciente para animales equinos y de compañía, ha anunciado su próxima conferencia telefónica sobre los resultados financieros del segundo trimestre de 2024. El evento está programado para el miércoles 14 de agosto de 2024, a las 4:30 p.m. ET. Durante la llamada, la gerencia discutirá los aspectos operativos y financieros del trimestre que finalizó el 30 de junio de 2024, seguido de una sesión de preguntas y respuestas.
Las partes interesadas pueden unirse a la llamada en vivo a través del teléfono o de la transmisión web. Para aquellos que no puedan asistir, habrá una repetición de la llamada disponible hasta el 28 de agosto de 2024. Este anuncio demuestra el compromiso de Zomedica con la transparencia y la comunicación con los accionistas, brindando a los inversores la oportunidad de obtener información sobre el desempeño reciente de la empresa y sus perspectivas futuras.
조메디카 코퍼레이션(Zomedica Corp.)(NYSE American:ZOM)은 말과 반려동물을 위한 진단 및 치료 제품을 전문으로 하는 수의학 건강 기업으로, 2024년 2분기 재무 결과에 대한 컨퍼런스 콜을 발표했습니다. 이 행사는 2024년 8월 14일 수요일 오후 4시 30분 ET에 예정되어 있습니다. 지난 2024년 6월 30일 종료된 분기의 운영 및 재무 주요 사항에 대해 경영진이 논의하고, 그 뒤에 질문 및 답변 세션이 진행될 것입니다.
관심 있는 분들은 전화 또는 웹캐스트를 통해 생중계에 참여할 수 있습니다. 참석이 어려운 분들을 위해 2024년 8월 28일까지 다이얼 인 재생이 가능합니다. 이번 발표는 조메디카가 투명성 및 주주 소통에 대한 헌신을 보여주며, 투자자들에게 회사의 최근 성과와 향후 전망에 대한 통찰을 제공할 기회를 제공합니다.
Zomedica Corp. (NYSE American:ZOM), une entreprise de santé vétérinaire spécialisée dans les produits de diagnostic et de thérapie pour animaux équins et de compagnie, a annoncé sa prochaine conférence téléphonique sur les résultats financiers du deuxième trimestre 2024. L'événement est prévu pour le mercredi 14 août 2024 à 16h30 ET. Lors de l'appel, la direction discutera des points saillants opérationnels et financiers pour le trimestre se terminant le 30 juin 2024, suivi d'une session de questions-réponses.
Les parties intéressées peuvent rejoindre l'appel en direct par téléphone ou par webcast. Pour ceux qui ne peuvent pas y assister, un replay sera disponible jusqu'au 28 août 2024. Cette annonce démontre l'engagement de Zomedica en matière de transparence et de communication avec ses actionnaires, offrant aux investisseurs l'opportunité d'obtenir des informations sur les performances récentes de l'entreprise et ses perspectives futures.
Zomedica Corp. (NYSE American:ZOM), ein Unternehmen für Veterinärgesundheit, das sich auf diagnostische und therapeutische Produkte für Pferde und Haustiere spezialisiert hat, hat seine bevorstehende Telefonkonferenz zu den Finanzergebnissen des zweiten Quartals 2024 angekündigt. Die Veranstaltung ist für Mittwoch, den 14. August 2024, um 16:30 Uhr ET angesetzt. Während des Anrufs wird die Geschäftsleitung die betrieblichen und finanziellen Höhepunkte für das am 30. Juni 2024 endende Quartal erörtern, gefolgt von einer Frage-und-Antwort-Runde.
Interessierte Parteien können an der Live-Konferenz per Telefon oder Webcast teilnehmen. Für diejenigen, die nicht teilnehmen können, wird eine Aufzeichnung bis zum 28. August 2024 verfügbar sein. Diese Ankündigung zeigt das Engagement von Zomedica für Transparenz und Kommunikation mit den Aktionären und bietet den Investoren die Möglichkeit, Einblicke in die jüngsten Leistungen des Unternehmens und seine zukünftigen Perspektiven zu gewinnen.
- None.
- None.
ANN ARBOR, MI / ACCESSWIRE / August 1, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, will host a conference call and audio-only webcast on Wednesday, August 14, 2024, at 4:30 p.m. ET to discuss the Company's operational and financial highlights for its second quarter ended June 30, 2024. A question-and-answer session will follow management's prepared remarks.
Event: Zomedica Corp. Q2 2024 Financial Results Conference Call
Date: Wednesday, August 14, 2024
Time: 4:30 p.m. Eastern Time
Live Call: +1-800-717-1738 (U.S. Toll-Free) or +1-646-307-1865 (International)
Webcast: LINK
For interested individuals unable to join the conference call, a dial-in replay of the call will be available until Wednesday, August 28, 2024 at 11:59 PM ET and can be accessed by dialing +1-844-512-2921 (U.S. Toll-Free) or +1-412-317-6671 (International) and entering replay pin number: 1166273
About Zomedica
Zomedica is a leading equine and companion animal healthcare company dedicated to improving animal health by providing veterinarians innovative therapeutic and diagnostic solutions. Our gold standard PulseVet® shock wave system, which accelerates healing in musculoskeletal conditions, has transformed veterinary therapeutics. Our suite of products also includes the Assisi® Loop line of therapeutic devices and the TRUFORMA® diagnostic platform, the TRUVIEW™ digital cytology system, and the VetGuardian® no-touch monitoring system, all designed to empower veterinarians to provide top-tier care. In the aggregate, their total addressable market in the U.S. exceeds
Follow Zomedica
Email Alerts: http://investors.zomedica.com
LinkedIn: https://www.linkedin.com/company/zomedica
X (formerly Twitter): https://x.com/zomedica
Facebook: https://m.facebook.com/zomedica
Instagram: https://www.instagram.com/zomedica_inc
SOURCE: Zomedica Corp.
View the original press release on accesswire.com
FAQ
When will Zomedica (ZOM) report its Q2 2024 financial results?
How can investors participate in Zomedica's (ZOM) Q2 2024 earnings call?
What period will Zomedica's (ZOM) Q2 2024 financial results cover?
Will there be a replay available for Zomedica's (ZOM) Q2 2024 earnings call?
